Foley Partner Jacqueline Wright Bonilla was quoted in an article that appeared in FDA Week on August 5, 2011 titled “Gene Patent Ruling’s Isolation v. Purification Distinction Could Impact Biotech.” Wright Bonilla discusses a federal court ruling on DNA patent eligibility that distinguishes between the terms isolation and purification. She states that the distinction is not clearly defined with regards to non-nucleic acid biologics and pharma molecules, adding that this distinction might be determined on a product-by-product basis and influence how attorneys draft their patent claims.
Related News
July 2, 2025
In the News
John Strom and Peter Tomasi Quoted on Shift in Environmental Policy
Foley & Lardner LLP attorneys John Strom and Peter Tomasi commented on changes to federal environmental rules in the Utility Dive article, "Federal agencies, including FERC and DOE, revoke environmental review rules."
June 30, 2025
In the News
Lynn Gandhi Assesses Midyear Takeaways from Major State and Local Tax Cases
Foley & Lardner LLP partner Lynn Gandhi is featured by Law360 for her takeaways on major state and local tax cases in the article, "Top State & Local Tax Cases Of 2025: Midyear Report."
June 27, 2025
In the News
Donald Schroeder Highlights FMCS Importance Amid Service's Uncertain Future
Foley & Lardner LLP partner Donald Schroeder described the Federal Mediation and Conciliation Services' (FMCS) importance in the Law360 article, "As Feds' Bargaining Mediator Ails, New Services Emerge."